AMLX 424B5: Secondary offering
Filed with the SEC on · accession 0001193125-26-359416
AMLX filed a 424B5 (prospectus (offering)) with the SEC on Aug 20, 2026. Amylyx Pharmaceuticals is offering 14,090,000 shares of common stock at $35.50 per share in an underwritten public offering, with an option for underwriters to purchase an additional 2,113,500 shares. The stock moved +2.7% by the first close after the filing.
Summary of the filing
Amylyx Pharmaceuticals is offering 14,090,000 shares of common stock at $35.50 per share in an underwritten public offering, with an option for underwriters to purchase an additional 2,113,500 shares. The offering is expected to raise approximately $472.2 million in net proceeds before expenses.
Key details
How AMLX stock reacted
Close before
$38.60
Aug 19, 2026
First close after
+2.75%
$39.66
5 trading days
-3.94%
$37.08
Since filing
-28.45%
$27.62
✦ Ask GOAX AI about this filing — what it means for AMLX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for AMLX?
Click hereFrequently asked questions
What did AMLX file with the SEC on Aug 20, 2026?
AMLX filed a 424B5 (Secondary offering). Amylyx Pharmaceuticals is offering 14,090,000 shares of common stock at $35.50 per share in an underwritten public offering, with an option for underwriters to purchase an additional 2,113,500 shares. The offering is expected to raise approximately $472.2 million in net proceeds before expenses.
What does a secondary offering mean for AMLX stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did AMLX stock react to this filing?
AMLX closed at $38.60 before the filing and $39.66 on Aug 20, 2026 (+2.75%). Five trading days later: $37.08 (-3.94%).
Other AMLX SEC filings
- 10-Q · SEC filingNov 5, 2026
- 8-K · SEC filingNov 5, 2026
- 8-K · Material agreementSep 8, 2026
- 8-K · Secondary offeringAug 20, 2026
- 8-K · Fda approvalAug 18, 2026
- 424B5 · Secondary offeringAug 18, 2026
- 8-K · Fda approvalAug 18, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · SEC filingAug 6, 2026
- 8-K · Board changeJun 4, 2026
Get alerts when AMLX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days